Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Other Comprehensive Income (Loss), Net of Tax

1.8 / 5 stars · 42/120 Roast Me

GILEAD SCIENCES, INC. Other Comprehensive Income (Loss), Net of Tax

GILEAD SCIENCES, INC. (GILD) reported Other Comprehensive Income (Loss), Net of Tax of -$93.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-02-24

  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $3.00M, a 94.92% decline year-over-year.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $55.00M.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$111.00M, a 562.50% decline year-over-year.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was -$40.00M, a 197.56% decline year-over-year.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for fiscal 2025 was -$93.00M, a 189.42% decline from fiscal 2024.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $104.00M, a 300.00% increase from fiscal 2023.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $26.00M.
  • GILEAD SCIENCES, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$81.00M, a 156.64% decline from fiscal 2021.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 3 month as first filedOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 6 month as first filedOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 9 month as first filedOther Comprehensive Income (Loss), Net of Tax 12 monthOther Comprehensive Income (Loss), Net of Tax 12 month as first filed
2025-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$58.00M
derived: sum of 2 quarters · filed 2026-02-24
-$53.00M
derived: sum of 3 quarters · filed 2026-02-24
-$93.00M
10-K · filed 2026-02-24
2025-09-30$55.00M
10-Q · filed 2025-11-07
-$56.00M
derived: sum of 2 quarters · filed 2025-11-07
-$96.00M
10-Q · filed 2025-11-07
-$37.00M
derived: sum of 4 quarters · filed 2026-02-24
2025-06-30-$111.00M
10-Q · filed 2025-08-07
-$150.00M
10-Q · filed 2025-08-07
-$92.00M
derived: sum of 3 quarters · filed 2026-02-24
-$112.00M
derived: sum of 4 quarters · filed 2026-02-24
2025-03-31-$40.00M
10-Q · filed 2025-05-07
$19.00M
derived: sum of 2 quarters · filed 2026-02-24
-$1.00M
derived: sum of 3 quarters · filed 2026-02-24
$23.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-12-31$59.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$39.00M
derived: sum of 2 quarters · filed 2026-02-24
$63.00M
derived: sum of 3 quarters · filed 2026-02-24
$104.00M
10-K · filed 2026-02-24
2024-09-30-$20.00M
10-Q · filed 2025-11-07
$4.00M
derived: sum of 2 quarters · filed 2025-11-07
$45.00M
10-Q · filed 2025-11-07
$41.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$24.00M
10-Q · filed 2025-08-07
$65.00M
10-Q · filed 2025-08-07
$61.00M
derived: sum of 3 quarters · filed 2026-02-24
$82.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$41.00M
10-Q · filed 2025-05-07
$37.00M
derived: sum of 2 quarters · filed 2026-02-24
$58.00M
derived: sum of 3 quarters · filed 2026-02-24
$89.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$4.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$17.00M
derived: sum of 2 quarters · filed 2026-02-24
$48.00M
derived: sum of 3 quarters · filed 2026-02-24
$26.00M
10-K · filed 2026-02-24
2023-09-30$21.00M
10-Q · filed 2024-11-12
$52.00M
derived: sum of 2 quarters · filed 2024-11-12
$30.00M
10-Q · filed 2024-11-12
-$66.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$31.00M
10-Q · filed 2024-08-08
$9.00M
10-Q · filed 2024-08-08
-$87.00M
derived: sum of 3 quarters · filed 2025-02-28
-$76.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31-$22.00M
10-Q · filed 2024-05-08
-$118.00M
derived: sum of 2 quarters · filed 2025-02-28
-$107.00M
derived: sum of 3 quarters · filed 2025-02-28
-$93.00M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$96.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$85.00M
derived: sum of 2 quarters · filed 2025-02-28
-$71.00M
derived: sum of 3 quarters · filed 2025-02-28
-$81.00M
10-K · filed 2025-02-28
2022-09-30$11.00M
10-Q · filed 2023-11-07
$25.00M
derived: sum of 2 quarters · filed 2023-11-07
$15.00M
10-Q · filed 2023-11-07
$24.00M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30$14.00M
10-Q · filed 2023-08-04
$4.00M
10-Q · filed 2023-08-04
$13.00M
derived: sum of 3 quarters · filed 2024-02-23
$48.00M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31-$10.00M
10-Q · filed 2023-05-03
-$1.00M
derived: sum of 2 quarters · filed 2024-02-23
$34.00M
derived: sum of 3 quarters · filed 2024-02-23
$35.00M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31$9.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$44.00M
derived: sum of 2 quarters · filed 2024-02-23
$45.00M
derived: sum of 3 quarters · filed 2024-02-23
$143.00M
10-K · filed 2024-02-23
2021-09-30$35.00M
10-Q · filed 2022-11-02
$36.00M
derived: sum of 2 quarters · filed 2022-11-02
$134.00M
10-Q · filed 2022-11-02
$51.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$1.00M
10-Q · filed 2022-08-08
$99.00M
10-Q · filed 2022-08-08
$16.00M
derived: sum of 3 quarters · filed 2023-02-22
-$31.00M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$98.00M
10-Q · filed 2022-05-04
$15.00M
derived: sum of 2 quarters · filed 2023-02-22
-$32.00M
derived: sum of 3 quarters · filed 2023-02-22
-$8.00M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$83.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
-$130.00M
derived: sum of 2 quarters · filed 2023-02-22
-$106.00M
derived: sum of 3 quarters · filed 2023-02-22
-$145.00M
10-K · filed 2023-02-22
2020-09-30-$47.00M
10-Q · filed 2021-11-03
-$23.00M
derived: sum of 2 quarters · filed 2021-11-03
-$62.00M
10-Q · filed 2021-11-03
-$94.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$24.00M
10-Q · filed 2021-08-05
-$15.00M
10-Q · filed 2021-08-05
-$47.00M
derived: sum of 3 quarters · filed 2022-02-23
-$32.00M
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31-$39.00M
10-Q · filed 2021-05-06
-$71.00M
derived: sum of 2 quarters · filed 2022-02-23
-$56.00M
derived: sum of 3 quarters · filed 2022-02-23
-$84.00M
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31-$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
-$17.00M
derived: sum of 2 quarters · filed 2022-02-23
-$45.00M
derived: sum of 3 quarters · filed 2022-02-23
$5.00M
10-K · filed 2022-02-23
2019-09-30$15.00M
10-Q · filed 2020-11-04
-$13.00M
derived: sum of 2 quarters · filed 2020-11-04
$37.00M
10-Q · filed 2020-11-04
$81.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$28.00M
10-Q · filed 2020-08-06
$22.00M
10-Q · filed 2020-08-06
$66.00M
derived: sum of 3 quarters · filed 2021-02-25
$100.00M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$50.00M
10-Q · filed 2020-05-06
$94.00M
derived: sum of 2 quarters · filed 2021-02-25
$128.00M
derived: sum of 3 quarters · filed 2021-02-25
$300.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$44.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$78.00M
derived: sum of 2 quarters · filed 2021-02-25
$250.00M
derived: sum of 3 quarters · filed 2021-02-25
$208.00M
10-K · filed 2021-02-25
2018-09-30$34.00M
10-Q · filed 2019-11-05
$206.00M
derived: sum of 2 quarters · filed 2019-11-05
$164.00M
10-Q · filed 2019-11-05
$80.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$172.00M
10-Q · filed 2019-08-06
$130.00M
10-Q · filed 2019-08-06
$46.00M
derived: sum of 3 quarters · filed 2020-02-25
$175.00M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$42.00M
10-Q · filed 2019-05-08
-$126.00M
derived: sum of 2 quarters · filed 2020-02-25
$3.00M
derived: sum of 3 quarters · filed 2020-02-25
-$137.00M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$84.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$45.00M
derived: sum of 2 quarters · filed 2020-02-25
-$95.00M
derived: sum of 3 quarters · filed 2020-02-25
-$113.00M
10-K · filed 2020-02-25
2017-09-30$129.00M
10-Q · filed 2018-11-06
-$11.00M
derived: sum of 2 quarters · filed 2018-11-06
-$29.00M
10-Q · filed 2018-11-06
$357.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30-$140.00M
10-Q · filed 2018-08-06
-$158.00M
10-Q · filed 2018-08-06
$228.00M
derived: sum of 3 quarters · filed 2019-02-26
$166.00M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$18.00M
10-Q · filed 2018-05-09
$368.00M
derived: sum of 2 quarters · filed 2019-02-26
$306.00M
derived: sum of 3 quarters · filed 2019-02-26
$424.00M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$386.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$324.00M
derived: sum of 2 quarters · filed 2019-02-26
$442.00M
derived: sum of 3 quarters · filed 2019-02-26
$190.00M
10-K · filed 2019-02-26
2016-09-30-$62.00M
10-Q · filed 2017-11-07
$56.00M
derived: sum of 2 quarters · filed 2017-11-07
-$196.00M
10-Q · filed 2017-11-07
-$275.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$118.00M
10-Q · filed 2017-08-07
-$134.00M
10-Q · filed 2017-08-07
-$213.00M
derived: sum of 3 quarters · filed 2018-02-27
-$293.00M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$252.00M
10-Q · filed 2017-05-10
-$331.00M
derived: sum of 2 quarters · filed 2018-02-27
-$411.00M
derived: sum of 3 quarters · filed 2018-02-27
-$703.00M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$79.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$159.00M
derived: sum of 2 quarters · filed 2018-02-27
-$451.00M
derived: sum of 3 quarters · filed 2018-02-27
-$213.00M
10-K · filed 2018-02-27
2015-09-30-$80.00M
10-Q · filed 2016-11-07
-$372.00M
derived: sum of 2 quarters · filed 2016-11-07
-$134.00M
10-Q · filed 2016-11-07
-$8.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$292.00M
10-Q · filed 2016-08-05
-$54.00M
10-Q · filed 2016-08-05
$72.00M
derived: sum of 3 quarters · filed 2017-02-27
$288.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$238.00M
10-Q · filed 2016-05-06
$364.00M
derived: sum of 2 quarters · filed 2017-02-27
$580.00M
derived: sum of 3 quarters · filed 2017-02-27
$634.00M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$126.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$342.00M
derived: sum of 2 quarters · filed 2017-02-27
$396.00M
derived: sum of 3 quarters · filed 2017-02-27
$425.00M
10-K · filed 2017-02-27
2014-09-30$216.00M
10-Q · filed 2015-11-04
$215.42M
10-Q · filed 2014-11-05
$270.00M
derived: sum of 2 quarters · filed 2015-11-04
$299.00M
10-Q · filed 2015-11-04
$298.41M
10-Q · filed 2014-11-05
$217.46M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30$54.00M
10-Q · filed 2015-08-05
$54.31M
10-Q · filed 2014-08-04
$83.00M
10-Q · filed 2015-08-05
$82.99M
10-Q · filed 2014-08-04
$1.46M
derived: sum of 3 quarters · filed 2016-02-24
-$70.99M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31$29.00M
10-Q · filed 2015-05-08
$28.68M
10-Q · filed 2014-05-07
-$52.55M
derived: sum of 2 quarters · filed 2016-02-24
-$124.99M
derived: sum of 3 quarters · filed 2016-02-24
-$115.42M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$81.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
-$153.99M
derived: sum of 2 quarters · filed 2016-02-24
-$144.42M
derived: sum of 3 quarters · filed 2016-02-24
-$78.00M
10-K · filed 2016-02-24
-$78.83M
10-K · filed 2014-02-25
2013-09-30-$72.44M
10-Q · filed 2014-11-05
-$62.88M
derived: sum of 2 quarters · filed 2014-11-05
$3.54M
10-Q · filed 2014-11-05
-$70.50M
derived: sum of 4 quarters · filed 2015-02-25
2013-06-30$9.56M
10-Q · filed 2014-08-04
$75.99M
10-Q · filed 2014-08-04
$1.94M
derived: sum of 3 quarters · filed 2015-02-25
-$94.19M
derived: sum of 4 quarters · filed 2015-02-25
2013-03-31$66.42M
10-Q · filed 2014-05-07
-$7.63M
derived: sum of 2 quarters · filed 2015-02-25
-$103.76M
derived: sum of 3 quarters · filed 2015-02-25
-$12.97M
derived: sum of 4 quarters · filed 2015-02-25
2012-12-31-$74.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25
-$170.18M
derived: sum of 2 quarters · filed 2015-02-25
-$79.39M
derived: sum of 3 quarters · filed 2015-02-25
-$104.00M
10-K · filed 2015-02-25
-$103.81M
10-K · filed 2013-02-27
2012-09-30-$96.13M
10-Q · filed 2013-10-31
-$5.34M
derived: sum of 2 quarters · filed 2013-10-31
-$29.95M
10-Q · filed 2013-10-31
$43.79M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30$90.79M
10-Q · filed 2013-08-01
$66.18M
10-Q · filed 2013-08-01
$139.92M
derived: sum of 3 quarters · filed 2014-02-25
$257.66M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$24.61M
10-Q · filed 2013-05-08
$49.13M
derived: sum of 2 quarters · filed 2014-02-25
$166.87M
derived: sum of 3 quarters · filed 2014-02-25
2011-12-31$73.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$191.48M
derived: sum of 2 quarters · filed 2014-02-25
$27.29M
10-K · filed 2014-02-25
2011-09-30$117.74M
10-Q · filed 2012-11-06
-$46.45M
10-Q · filed 2012-11-06
2010-12-31$36.67M
10-K · filed 2013-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31